Phillip A. Sharp
DirectoratAlnylam Pharmaceuticals· In proxies 2023–2025
Phillip A. Sharp sits on 4 public boards.
Boards1
- Alnylam PharmaceuticalsDirector · 21 yr on the boardIndependentScience and Technology (Chair)—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Alnylam PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role 0%
- Vir Biotechnology, Inc.Public company
- Director? – PresentNo stock prices for these years
- Biogen Inc.Public company
- Director? – PresentNo stock prices for these years
- Syros Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?